Work

Who Benefits Most from Adjuvant Durvalumab after Chemoradiotherapy for Non-Small Cell Lung Cancer?

Year: 2020

Type: article

Study design: Observational Study

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2020.07.1179

Authors: N. Ohri, B. Halmos, W.R. Bodner, H. Cheng, M.K. Garg, R. Gucalp, C. Guha

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3093907124

FWCI: 0.124

Cites:

Cited by: 1

Related to: 10